Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NexgenRxTSXV:NXG 55 OCF Yield % is 9.41 as of Jul. 31, 2026, which is 30% above its 10-year median of 7.23. GuruFocus rates TSXV:NXG with a GF Score™ of 55/100 and a GF Value™ of C$0.33 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 682 Healthcare Providers & Services companies, NexgenRx ranks better than 66.28% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for NexgenRx's OCF Yield % or its related term are showing as below:
TSXV:NXG'
s OCF Yield % Range Over the Past 10 Years
Min: -6.98 Med: 7.23 Max: 24.23
Current: 9.41
During the past 13 years, the highest OCF Yield % of NexgenRx was 24.23%. The lowest was -6.98%. And the median was 7.23%.
TSXV:NXG's OCF Yield % is ranked better than 66.28% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 5.58
vs TSXV:NXG: 9.41
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
NexgenRx OCF Yield % Related Terms
NexgenRx OCF Yield % Historical Data
* Premium members only.
The historical data trend for NexgenRx's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:NXG vs VEEV, BTSG, HQY: OCF Yield % Comparison
For the Health Information Services subindustry, NexgenRx's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NexgenRx OCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NexgenRx's OCF Yield % distribution charts can be found below:
* The bar in red indicates where NexgenRx's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NexgenRx (TSXV:NXG) has a OCF Yield % of 9.41 as of Jul. 31, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on NexgenRx and its competitors. This is 30% above median its historical median of 7.23. According to the industry distribution chart, NexgenRx ranks #230 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 33.7%.
Is NexgenRx's OCF Yield % too high?
NexgenRx's current OCF Yield % of 9.41 is 30% above median its 10-year median of 7.23. The Healthcare Providers & Services industry median OCF Yield % is 5.58. NexgenRx's value of 9.41 is 68.6% above this industry median. Based on the distribution chart, NexgenRx ranks #230 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, NexgenRx has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NexgenRx's OCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NexgenRx ranks #230 out of 682 companies for OCF Yield %. This puts NexgenRx in the upper half of its industry. The industry median OCF Yield % is 5.58. NexgenRx's value of 9.41 is 68.6% above this benchmark. While the company's 10-year median is 7.23 vs. the industry median of 5.58, NexgenRx has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Healthcare Providers & Services company?
The median OCF Yield % among Healthcare Providers & Services companies is 5.58, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NexgenRx's current OCF Yield % of 9.41 is 68.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on NexgenRx and its competitors. For the Healthcare Providers & Services industry, the median OCF Yield % is 5.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NexgenRx's current OCF Yield % is 9.41, which is 30% above median its own 10-year median of 7.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NexgenRx stock overvalued right now?
Based on GuruFocus' analysis, NexgenRx (TSXV:NXG) is currently considered Significantly Overvalued. The stock's GF Value™ is C$0.33, compared to a current price of C$0.65 — trading 97% above its estimated fair value. The current OCF Yield % is 9.41, which is 30% above median its 10-year median of 7.23 and 68.6% above the Healthcare Providers & Services industry median of 5.58. NexgenRx's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For NexgenRx (TSXV:NXG), the current OCF Yield % is 9.41 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NexgenRx (TSXV:NXG) Overvalued in 2026?
Based on GuruFocus' analysis, NexgenRx stock appears to be overvalued.
The current stock price of C$0.65 is trading 97% above its estimated GF Value™ of C$0.33.
GuruFocus considers NexgenRx to be Significantly Overvalued.
Key valuation signals for TSXV:NXG:
OCF Yield %: 9.41 (30% above median its 10-year median of 7.23)
GF Value™: C$0.33 vs. price of C$0.65 (97% above fair value)
Industry Position: 68.6% above the Healthcare Providers & Services median (#230 of 682)
No single metric tells the full story. See the TSXV:NXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NexgenRx Inc administers, adjudicates, and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers using proprietary computer software and also provides ancillary services. The various solutions offered by the company include: NexSys, a fully integrated rules-based adjudication platform for real-time processing of drug, dental, and extended health benefit claims; NexAdmin, which enables sponsors to take complete control of benefit plan administration; and NexPSPAssist, a service that helps Patient Support Programs (PSP) to optimize their deliverables to their manufacturer clients. The company has only one operating segment - benefits administration services.
55GF Score
Get the complete analysis for TSXV:NXG
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:NXG has been successfully added to your 
